Recommended Citation
Published in 235th National Meeting Of The American Chemical Society Proceedings: New Orleans, Louisiana, April 7, 2008.
NOTE: At the time of publication, the author Hasan Palandoken was not yet affiliated with Cal Poly.
Abstract
The sodium proton exchanger (NHE) is particularly important in maintaining the intracellular pH in human heart and brain. Under anaerobic conditions (i.e., ischemia), a shift from oxidative to nonoxidative glycolysis occurs. The resultant decrease in the intracellular pH activates NHE, which increases the intracellular sodium, initiating the sequence of physiological events that lead to cell death. Thus, there has been great interest in the development of compounds that inhibit NHE. Indeed, potent NHE inhibitors are available. However, a fundamental impediment to the field is the delivery of these compounds to poorly vascularized tissues during the early phases of ischemia when NHE inhibition is most beneficial. We have synthesized analogs of cariporide, a potent (e.g., nanomolar IC50 activity) NHE inhibitor, to address these temporal and delivery challenges. The preparation and biological activities of our cariporide analogs will be discussed.
Disciplines
Biochemistry | Chemistry
Copyright
2008 American Chemical Society .
Included in
URL: https://digitalcommons.calpoly.edu/chem_fac/21